Evaluation and prospects for the introduction of VMAT for the purpose of reducing pericardial effusion after radical CRT for esophageal cancer
Not Applicable
- Conditions
- Thoracic esophageal squamous cell carcinoma
- Registration Number
- JPRN-UMIN000043452
- Lead Sponsor
- Keiyukai Sapporo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 158
Inclusion Criteria
Not provided
Exclusion Criteria
Age is over 80 years old Chemotherapy cannot be given due to complications
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method